Morgan Stanley Reinstates Equal-Weight on Exelixis, Announces $21 Price Target
Portfolio Pulse from richadhand@benzinga.com
Morgan Stanley analyst Jefferson Harralson has reinstated Exelixis (NASDAQ:EXEL) with an Equal-Weight rating and announced a $21 price target.
July 11, 2023 | 9:06 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Exelixis has been reinstated with an Equal-Weight rating by Morgan Stanley, with a price target of $21.
The reinstatement of Exelixis by Morgan Stanley with an Equal-Weight rating indicates a neutral outlook for the stock. The price target of $21 suggests where the analyst believes the stock price may reach, but it doesn't necessarily imply a strong upward or downward movement in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100